Stockreport

4D Molecular Therapeutics taps Kristian Humer as CFO [Seeking Alpha]

Foghorn Therapeutics Inc.  (FHTX) 
PDF Humer is a seasoned finance executive and biotechnology leader with more than two decades of experience, including at Citi, Foghorn Therapeutics, and Viridian Therapeut [Read more]